Catalyst Wire Dossier Catalyst Wire Dossier

Tenofovir disoproxil

Tenofovir disoproxil · Samjin Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tenofovir disoproxil, covering 2021-05-27 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B [Phase 4]

See pricing